Skip to main content

Peer Review reports

From: Real-life assessment of aripiprazole monthly (Abilify Maintena) in schizophrenia: a Canadian naturalistic non-interventional prospective cohort study

Original Submission
23 Nov 2018 Submitted Original manuscript
26 Dec 2018 Reviewed Reviewer Report - Lone Baandrup
18 Jan 2019 Reviewed Reviewer Report - Pirathiv Kugathasan
19 Feb 2019 Author responded Author comments - Sally Mustafa
Resubmission - Version 2
19 Feb 2019 Submitted Manuscript version 2
8 Mar 2019 Reviewed Reviewer Report - Pirathiv Kugathasan
14 Mar 2019 Reviewed Reviewer Report - Lone Baandrup
23 Mar 2019 Author responded Author comments - Sally Mustafa
Resubmission - Version 3
23 Mar 2019 Submitted Manuscript version 3
27 Mar 2019 Reviewed Reviewer Report - Pirathiv Kugathasan
3 Apr 2019 Author responded Author comments - Sally Mustafa
Resubmission - Version 4
3 Apr 2019 Submitted Manuscript version 4
Publishing
4 Apr 2019 Editorially accepted
16 Apr 2019 Article published 10.1186/s12888-019-2103-x

You can find further information about peer review here.

Back to article page